Evidence map›Paper›PMID 34002024›Full record

ArticleThe ISME journal2021

Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients.

Yueqiong Ni, Zoltan Lohinai, Yoshitaro Heshiki, Balazs Dome, Judit Moldvay, Edit Dulka, Gabriella Galffy, Judit Berta, Glen J Weiss, Morten O A Sommer and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The ISME journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 2 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 2 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Yueqiong Ni *Leibniz Institute for Natural Product Research and Infection Biology-Hans Knöll Institute, Jena, Germany.ORCID http://orcid.org/0000-0003-1285-7354
Zoltan Lohinai *National Koranyi Institute of Pulmonology, Budapest, Hungary.
Yoshitaro HeshikiLeibniz Institute for Natural Product Research and Infection Biology-Hans Knöll Institute, Jena, Germany.
Balazs DomeNational Koranyi Institute of Pulmonology, Budapest, Hungary.
Judit MoldvayNational Koranyi Institute of Pulmonology, Budapest, Hungary.
Edit DulkaCounty Hospital of Torokbalint, Torokbalint, Hungary.
Gabriella GalffyCounty Hospital of Torokbalint, Torokbalint, Hungary.
Judit BertaNational Koranyi Institute of Pulmonology, Budapest, Hungary.
Glen J WeissMiRanostics Consulting, Oro Valley, AZ, USA.
Morten O A SommerNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens, Denmark.ORCID http://orcid.org/0000-0003-4005-5674
Gianni PanagiotouLeibniz Institute for Natural Product Research and Infection Biology-Hans Knöll Institute, Jena, Germany. gianni.panagiotou@leibniz-hki.de.ORCID http://orcid.org/0000-0001-9393-124X
Országos Korányi Tbc és Pulmonológiai Intézet · HULeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEChinese University of Hong Kong · HKNovo Nordisk Foundation · DK

Funding

Austrian Science Fund FWF I 3977Austrian Science Fund FWF I 4677
6 · The paper itself

Abstract

Cachexia is associated with decreased survival in cancer patients and has a prevalence of up to 80%. The etiology of cachexia is poorly understood, and limited treatment options exist. Here, we investigated the role of the human gut microbiome in cachexia by integrating shotgun metagenomics and plasma metabolomics of 31 lung cancer patients. The cachexia group showed significant differences in the gut microbial composition, functional pathways of the metagenome, and the related plasma metabolites compared to non-cachectic patients. Branched-chain amino acids (BCAAs), methylhistamine, and vitamins were significantly depleted in the plasma of cachexia patients, which was also reflected in the depletion of relevant gut microbiota functional pathways. The enrichment of BCAAs and 3-oxocholic acid in non-cachectic patients were positively correlated with gut microbial species Prevotella copri and Lactobacillus gasseri, respectively. Furthermore, the gut microbiota capacity for lipopolysaccharides biosynthesis was significantly enriched in cachectic patients. The involvement of the gut microbiome in cachexia was further observed in a high-performance machine learning model using solely gut microbial features. Our study demonstrates the links between cachectic host metabolism and specific gut microbial species and functions in a clinical setting, suggesting that the gut microbiota could have an influence on cachexia with possible therapeutic applications.

Indexed as

Gastrointestinal MicrobiomeLung NeoplasmsCachexiaHumansPrevotella

Identifiers

PMID34002024
PMCPMC8528809
OpenAlexW3160266111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.